If you were to stop a (relatively technical) stranger on the street and ask what AI is, chances are they would describe a ...

Here, we expand the repertoire of PROTAC compatible E3 ligases by identifying a novel small molecule scaffold targeting the ubiquitin E3 ligase KLHDC2 using a fluorescence polarization-based high ...

Ainnocence’s CarbonAI® Platform for AI-Powered Small Molecule Drug Design — Enabling De Novo Generation, Lead Optimization, ...

Small language models should be more cost effective to deploy than LLMs, offering greater privacy, and performing specific or tightly-defined tasks. But is it early days for SLMs?

Researchers expect LICONN technology will be broadly useful to enable high-resolution tissue analysis in other organs and ...

This manuscript characterizes a mutated clone of RNA polymerase I in yeast, referred to as SuperPol, to understand the mechanisms of RNA polymerase I elongation and termination. The authors present ...

As we continue to see sequencing technologies advance and provide a deeper understanding of gene therapy targets along with ...

Discover how scientists program nanomaterials to react to environmental triggers, leading to innovations in targeted drug delivery, self-healing materials, and smart electronics.

After a slow start in the electric cars space, the small car sector is finally catching up – and 2025 marks a turning point. We’re seeing a wave of exciting new models offering better value, more ...

Equity Insider News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, May 5, 2025 /PRNewswire/ --The integration of artificial intelligence (AI) into healthcare ...

At the regulatory level, the World Health Organization (WHO) recently announced a major global initiative to set unified standards for AI in healthcare, the US Food and Drug Administration (FDA) is ...

Revenue: Total revenue, consisting primarily of revenue from collaboration agreements, was $15 million for the first quarter ...